Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...
New and existing technologies, as well as a patient-centric focus, are pushing drug formulation into exciting directions. There are a variety of factors pushing innovation in formulation of drug ...
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback